Note: This document has been translated from a part of the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail. The Company assumes no responsibility for this translation or for direct, indirect or any other forms of damages arising from the translation.
Stock Exchange Code 4530 May 2, 2024 (Start date of measures for electronic provision: April 26, 2024)
To Shareholders with Voting Rights:
Kazuhide Nakatomi
President & CEO
Hisamitsu Pharmaceutical Co., Inc.
408 Tashiro Daikan-machi, Tosu, Saga
NOTICE OF CONVOCATION OF
THE 122ND ANNUAL GENERAL MEETING OF SHAREHOLDERS
We would like to express our appreciation for your continued support and patronage.
We would also like to express our heartfelt sympathy to all those affected by the 2024 Noto Peninsula Earthquake and sincerely hope for the earliest possible recovery.
This is to notify you that the 122nd Annual General Meeting of Shareholders of Hisamitsu Pharmaceutical Co., Inc. (the "Company") will be held for the purposes as described below.
In convening the General Meeting of Shareholders, the Company has taken measures for electronic provision and has posted the matters subject to electronic provision on the Company's website. Please access the Company's website below to see the information.
The Company's website https://global.hisamitsu/ir/shareholders.html
In addition to the Company's website, the matters subject to electronic provision are also posted on the website of the Tokyo Stock Exchange (TSE). When you access the TSE website, search for the Company by entering "Hisamitsu Pharmaceutical" in the "Issue name (company name)" bar or the Company's stock exchange code "4530" in the "Code" bar, continue selecting "Basic information" and "Documents for public inspection/PR information" and choose "Notice of General Shareholders Meeting/Informational Materials for a General Shareholders Meeting" under "Filed information available for public inspection" to see the matters.
TSE website (Listed Company Search) https://www2.jpx.co.jp/tseHpFront/JJK020010Action.do?Show=Show
In lieu of attending the meeting, you may exercise your voting rights via electromagnetic means, including the Internet, or in writing. In this case, please review the attached Reference Documents for the General Meeting of Shareholders and exercise your voting rights.
1. | Date and Time: | Thursday, May 23, 2024 at 10:00 a.m. Japan time |
2. | Place: | Head office of the Company located at |
408 Tashiro Daikan-machi, Tosu, Saga, Japan |
- 1 -
3. Meeting Agenda:
Matters to be reported: 1. The Business Report, Consolidated Financial Statements and Non-
consolidated Financial Statements for the Company's 122nd Fiscal Year (March 1, 2023 - February 29, 2024)
2. Results of audits by the Independent Auditor and the Board of Corporate Auditors of the Consolidated Financial Statements for the Company's 122nd Fiscal Year
Proposals to be resolved:
Proposal 1: Appropriation of Surplus
Proposal 2: Election of 9 Directors
Proposal 3: Election of 3 Corporate Auditors
(The details of the meeting agenda and other matters are stated in the following pages.)
4. Matters decided for convocation
- Items not stated in a document delivered to shareholders
The document delivered to shareholders also serves as a document that states the matters subject to electronic provision, which is delivered to shareholders who have requested a paper copy of it. In accordance with applicable laws and regulations and Article 14 of the Articles of Incorporation of the Company, the following items are not included in it. Please note that the Corporate Auditors and the Independent Auditor have audited documents, including the following items.
- Matters Regarding Share Acquisition Rights, etc. of the Company, Status of Independent Auditor, and Structure and Policy of the Company in the Business Report
- Consolidated Statements of Changes in Shareholders' Equity and Notes to Consolidated Financial Statements in the Consolidated Financial Statements
- Non-consolidatedStatement of Changes in Shareholders' Equity and Notes to Non-consolidated Financial Statements in the Non-consolidated Financial Statements
- 2 -
Reference Documents for the General Meeting of Shareholders
Proposal 1: Appropriation of Surplus
The Company regards the appropriate return of profits to shareholders as one of the most important management issues.
With respect to dividends of surplus at the end of the fiscal year under review, upon comprehensively examining factors such as the performance for the fiscal year, dividend payout ratios and various management measures for the future in addition to taking into account the stable distribution of dividends to shareholders, the Company proposes to pay a dividend of ¥42.5 per share as follows. Accordingly, the annual dividend including an interim dividend of ¥42.5 will be ¥85 per share, an increase from the annual dividend of ¥84.5 per share for the previous fiscal year.
In addition, the Company recognizes the need to strengthen its financial structure to provide for the stable return of profits to its shareholders and future business development, and therefore intends to allocate ¥3.0 billion to general reserve as follows.
1. Matters concerning dividends of surplus
- Allotment of dividend properties to shareholders and the total amount thereof
¥42.5 per share of the Company's common stock | Total payment of dividends: ¥3,220,341,578 |
- Effective date of dividends of surplus Friday, May 24, 2024
2. Matters concerning appropriation of surplus
- Surplus item to be increased and the amount thereof
General reserve | ¥3,000,000,000 |
(2) Surplus item to be decreased and the amount thereof | |
Retained earnings brought forward | ¥3,000,000,000 |
- 3 -
Proposal 2: Election of 9 Directors
No.
1
2
The terms of office of all 9 Directors will expire at the conclusion of this General Meeting of Shareholders. Accordingly, the election of 9 Directors is proposed.
The candidates for Directors are as follows:
Name | Past experience, positions, responsibilities | Number of | Special | |
shares of the | interests in the | |||
(Date of birth) | and significant concurrent positions | |||
Company held | Company | |||
April 1999 | Joined the Company | |||
February 2007 | Head of Corporate Strategy Planning | |||
Kazuhide Nakatomi | May 2007 | Director & Executive Officer | ||
(June 30, 1972) | May 2009 | Managing Director & Executive Officer | 245,742 | None |
May 2011 | Senior Managing Director & Executive Officer | |||
[Reappointment] | May 2014 | Vice President & Executive Officer | ||
May 2015 | President & COO | |||
May 2019 | President & CEO (to present) |
[Reason for nomination as candidate]
Mr. Kazuhide Nakatomi has extensive operational experience in the corporate strategy planning division, and took office as Director of the Company in 2007. He also has built track records as a corporate manager since he became Representative Director in 2015. We believe he is suitable for continuing to serve as a Director of the Company, and nominate him as a candidate for Director.
April 1977 | Joined the Company | |||
May 1999 | Director | |||
Kosuke Sugiyama | February 2010 | Director & Executive Officer | ||
(April 28, 1952) | July 2012 | Managing Director & Executive Officer | 13,000 | None |
May 2014 | Senior Managing Director & Executive Officer | |||
[Reappointment] | ||||
[In charge of Human Resources, Research and | ||||
Development, and Corporate Strategy Planning] (to | ||||
present) |
[Reason for nomination as candidate]
Mr. Kosuke Sugiyama has extensive operational experience in the human resources division, and has been managing and supervising management in general, including human resources, since he took office as Director of the Company in 1999. We believe he is suitable for continuing to serve as a Director of the Company, and nominate him as a candidate for Director.
- 4 -
No.
3
Name | Past experience, positions, responsibilities | |
(Date of birth) | and significant concurrent positions | |
April 1987 | Joined the Company | |
April 2009 | Executive Officer | |
May 2013 | Director & Executive Officer | |
Kyu Saito | May 2023 | Managing Director & Executive Officer |
[Head of Global Business Strategy, Chairman of | ||
(June 10, 1963) | ||
Hisamitsu America, Inc., President of Hisamitsu | ||
[Reappointment] | Pharmaceutical Technology Consulting (Beijing) Co., | |
Ltd., President of Hisamitsu Pharmaceutical (China) | ||
Co., Ltd., President of Hisamitsu U.S., Inc., and | ||
Director of P.T. Hisamitsu Pharma Indonesia] (to | ||
present) |
Number of | Special |
shares of the | interests in the |
Company held | Company |
7,100 None
4
[Reason for nomination as candidate]
Mr. Kyu Saito has extensive operational experience in the sales and corporate strategy planning divisions, and has been managing and supervising the overseas sales division since he took office as Director of the Company in 2013. We believe he is suitable for continuing to serve as a Director of the Company, and nominate him as a candidate for Director.
April 1988 | Joined the Company | |||
Nobuo Tsutsumi | March 2010 | Executive Officer | ||
May 2014 | Director & Executive Officer | |||
(March 11, 1964) | ||||
[Management of Legal Affairs, Production, Quality | 5,200 | None | ||
Assurance & Pharmacovigilance, Compliance, and Director of Yutoku Pharmaceutical Ind. Co., Ltd. (part- time)] (to present)
[Reason for nomination as candidate]
Mr. Nobuo Tsutsumi has extensive operational experience in the legal division, and has been managing and supervising legal affairs and compliance based on his high expertise since he took office as Director of the Company in 2014. We believe he is suitable for continuing to serve as a Director of the Company, and nominate him as a candidate for Director.
March 1991 | Joined the Company | |||
Shinichi Murayama | March 2012 | Executive Officer | ||
May 2014 | Director & Executive Officer | |||
(October 16, 1967) | 6,000 | None | ||
[Management of Internal Audit, Japan Subsidiaries, | ||||
[Reappointment] | Director of Yutoku Pharmaceutical Ind. Co., Ltd. (part- | |
time), and Outside Corporate Auditor of SANOFI- | ||
5 | ||
HISAMITSU K.K. (part-time)] (to present) | ||
[Reason for nomination as candidate]
Mr. Shinichi Murayama has extensive operational experience in the sales and corporate strategy planning divisions, and has been managing and supervising management in general, including as Executive Secretary of Chairman's Office, since he took office as Director of the Company in 2014. We believe he is suitable for continuing to serve as a Director of the Company, and nominate him as a candidate for Director.
- 5 -
No.
6
Name | Past experience, positions, responsibilities | |
(Date of birth) | and significant concurrent positions | |
April 1994 | Joined the Company | |
Koji Takiyama | May 2017 | Executive Officer |
May 2021 | Senior Executive Officer | |
(October 31, 1971) | ||
May 2022 | Director & Executive Officer | |
[Reappointment] | [Executive Secretary of President's Office, and |
Management of Digital Transformation (DX), and | |
Sustainability Promotion] (to present) |
Number of | Special |
shares of the | interests in the |
Company held | Company |
3,035 | None |
[Reason for nomination as candidate]
Mr. Koji Takiyama has extensive operational experience in the sales division and in the management of Hisamitsu Pharmaceutical Group companies, and has been managing and supervising management in general, including as Executive Secretary of President's Office, since he took office as Director of the Company in 2022. We believe he is suitable for
continuing to serve as a Director of the Company, and nominate him as a candidate for Director. | ||||
April 1988 | Professor of Faculty of Science and Technology, Keio | |||
University, Professor of Graduate School of Science | ||||
and Technology, Keio University | ||||
October 1993 | Dean of Faculty of Science and Technology, Keio | |||
University | ||||
Dean of Graduate School of Science and Technology, | ||||
Keio University | ||||
May 2001 | President of Keio University (Chair of the Board of | |||
Trustees of Keio University and the university | ||||
Yuichiro Anzai | president of Keio University) | |||
May 2009 | Advisor for Academic Affairs to Keio University (to | |||
(August 29, 1946) | present) | |||
April 2010 | Director of the Nakatomi Foundation (to present) | 300 | None | |
June 2011 | Chairman of Japanese Association of University | |||
Physical Education and Sports | ||||
October 2011 | President of Japan Society for the Promotion of Science | |||
(JSPS) | ||||
April 2012 | Professor Emeritus of Keio University (to present) | |||
February 2018 | President of Kojunsha Club (to present) | |||
April 2018 | Senior Advisor to JSPS (to present) | |||
Director of Research Center for Science Systems, JSPS | ||||
May 2020 | Outside Director of the Company (to present) | |||
July 2020 | Executive Director of The Tokyo Foundation for Policy | |||
Research | ||||
December 2020 | Executive Director and Chief Executive Officer of The | |||
Tokyo Foundation for Policy Research (to present) |
[Reason for nomination as candidate and summary of expected roles]
Mr. Yuichiro Anzai, who has long served as a manager of a university, has a wide range of knowledge and experience, and we expect him to provide precise advice on the Company's management. Furthermore, there is no problem with his independence in relationship with the Company. We believe he is suitable for continuing to serve as an Outside Director of the Company, and nominate him as a candidate for Outside Director.
- 6 -
Name | Past experience, positions, responsibilities | Number of | Special | ||
No. | shares of the | interests in the | |||
(Date of birth) | and significant concurrent positions | ||||
Company held | Company | ||||
April 2001 | Joined Matsuo Construction Co., Ltd. | ||||
June 2005 | Managing Director of Matsuo Construction Co., Ltd. | ||||
Tetsugo Matsuo | June 2006 | President of Matsuo Construction Co., Ltd. (to present) | |||
June 2012 | Outside Director of FM Saga Co., Ltd. (to present) | ||||
(January 1, 1972) | |||||
June 2013 | Outside Director of Saga Ube Concrete Kogyo Co., | ||||
1,900 | None | ||||
[Reappointment] | Ltd. (to present) | ||||
May 2016 | Chairman of Saga General Construction Association (to | ||||
[Outside Director] | |||||
present) | |||||
8 | [Independent Officer] | ||||
May 2020 | Outside Director of the Company (to present) | ||||
June 2023 | Outside Director of New Otani Kyushu Co., Ltd. (to | ||||
present) | |||||
[Reason for nomination as candidate and summary of expected roles] | |||||
Mr. Tetsugo Matsuo has extensive experience and insight into overall management acquired as a representative director of a | |||||
construction company, and we expect him to provide precise advice on the Company's management. Furthermore, there is no | |||||
problem with his independence in relationship with the Company. We believe he is suitable for continuing to serve as an | |||||
Outside Director of the Company, and nominate him as a candidate for Outside Director. | |||||
April 2004 | Joined KPMG AZSA LLC | ||||
May 2006 | Registered as a certified public accountant | ||||
Tamako Watanabe | April 2008 | Joined ASG Tax Corporation | |||
August 2010 | Registered as a certified tax accountant | ||||
(January 26, 1982) | |||||
July 2011 | Joined Odaki Accounting, Tax and Consulting | ||||
0 | None | ||||
[Reappointment] | General Manager of Tateyama Office | ||||
September 2011 | Registered as a licensed social insurance consultant | ||||
[Outside Director] | |||||
July 2019 | Established Itsuki Accounting Firm | ||||
9 | [Independent Officer] | ||||
Representative (to present) | |||||
May 2023 | Outside Director of the Company (to present) | ||||
December 2023 | Outside Auditor of SHOEI CO., LTD. (to present) |
[Reason for nomination as candidate and summary of expected roles]
Ms. Tamako Watanabe has a wide range of knowledge and experience acquired as a certified public accountant, a certified tax accountant and a licensed social insurance consultant, and we expect her to provide precise advice on the Company's management. Furthermore, there is no problem with her independence in relationship with the Company. We believe she is suitable for continuing to serve as an Outside Director of the Company, and nominate her as a candidate for Outside Director.
(Notes) | |
1. | Messrs. Yuichiro Anzai and Tetsugo Matsuo and Ms. Tamako Watanabe are candidates for Outside Directors. |
2. | Messrs. Yuichiro Anzai and Tetsugo Matsuo and Ms. Tamako Watanabe, candidates for Outside Directors, satisfy the |
requirements of independent officers stipulated by Tokyo Stock Exchange, Inc., Nagoya Stock Exchange, Inc. and | |
Fukuoka Stock Exchange, respectively, and the Company has notified these stock exchanges of them as independent | |
officers. | |
3. | At the conclusion of this General Meeting of Shareholders, Messrs. Yuichiro Anzai and Tetsugo Matsuo will have served |
for four years, and Ms. Tamako Watanabe will have served for one year as Outside Directors of the Company. | |
4. | The Company has entered into agreements with Messrs. Yuichiro Anzai and Tetsugo Matsuo and Ms. Tamako Watanabe |
in accordance with Article 427, Paragraph 1 of the Companies Act, to limit the liability for damages set forth in Article | |
423, Paragraph 1 of the same act to the amount stipulated by laws and regulations. If this proposal is approved, the | |
Company plans to continue the said agreements with them. | |
5. | The Company has concluded a directors and officers liability insurance contract with an insurance company, and all |
candidates for this election proposal will be insured under the contract. The insurance contract covers damages that may | |
arise from the insured directors and officers assuming liability for the execution of their duties or receiving claims related | |
to the pursuit of such liability. |
- 7 -
No.
1
2
Proposal 3: Election of 3 Corporate Auditors
The term of office of Messrs. Nobuyuki Nakatomi, Munehiko Hirano and Keinosuke Ono, 3 of the total 4 Corporate Auditors, will expire at the conclusion of this General Meeting of Shareholders. Accordingly, the election of three Corporate Auditors is proposed.
The Board of Corporate Auditors has given its consent to this proposal. The candidates for Corporate Auditor are as follows:
Name | Number of | Special | ||
Past experience, positions and significant concurrent positions | shares of the | interests in the | ||
(Date of birth) | ||||
Company held | Company | |||
Nobuyuki Nakatomi | September 1988 | Joined Cable Television Kurume Co., Ltd. | ||
(September 7, 1940) | April 1990 | President of Cable Television Kurume Co., Ltd. | 250,200 | None |
May 1999 | Director of the Company | |||
[Reappointment] | May 2008 | Corporate Auditor of the Company (to present) |
[Reason for nomination as candidate]
Mr. Nobuyuki Nakatomi has long been engaged in management of Hisamitsu Pharmaceutical Group companies and has extensive experience of managing and supervising management of the Company in general as Director. Based on the experience, he has been auditing the Company since he took office as Corporate Auditor of the Company in 2008. We believe he is suitable for continuing to serve as a Corporate Auditor of the Company and nominate him as a candidate for Corporate Auditor.
April 1974 | Joined the Company | ||
April 1997 | Head of Pharmaceutical Formulation | ||
Munehiko Hirano | Laboratories, Research and Development | ||
(September 20, 1947) | Headquarters of the Company | 2,300 | None |
February 2005 | General Manager in charge of Pharmaceutical | ||
[Reappointment] | Formulation Technology, Research and | ||
Development Headquarters of the Company | |||
May 2006 | Corporate Auditor of the Company (to present) |
[Reason for nomination as candidate]
Mr. Munehiko Hirano has extensive operational experience in the research and development division. Based on the experience, he has been auditing the Company since he took office as Corporate Auditor of the Company in 2006. We believe he is suitable for continuing to serve as a Corporate Auditor of the Company and nominate him as a candidate for Corporate Auditor.
- 8 -
Name | Number of | Special | |||
No. | Past experience, positions and significant concurrent positions | shares of the | interests in the | ||
(Date of birth) | |||||
Company held | Company | ||||
March 1979 | Joined the Mitsui Bank, Limited (currently | ||||
Sumitomo Mitsui Banking Corporation) | |||||
April 2006 | Executive Officer and General Manager of | ||||
Consumer Loan Dept. of Sumitomo Mitsui | |||||
Banking Corporation | |||||
Ryusuke Itakura | April 2007 | Executive Officer and Deputy Head of | |||
Consumer Banking Unit (in charge of West | |||||
(November 17, 1955) | |||||
Japan) of Sumitomo Mitsui Banking | |||||
[New Appointment] | Corporation | 0 | None | ||
June 2009 | Representative Director and President of SMBC | ||||
[Outside Corporate Auditor] | |||||
3 | [Independent Officer] | Guarantee Co., Ltd. | |||
June 2013 | Representative Director and President of | ||||
Muromachi Building Service Co., Ltd. | |||||
May 2019 | Director of Tanioka Gakuen Educational | ||||
Foundation (to present) | |||||
June 2019 | Outside Audit & Supervisory Board Member of | ||||
Futaba Industrial Co., Ltd. |
[Reason for nomination as candidate]
Mr. Ryusuke Itakura has knowledge of finance he acquired over many years in the financial industry and experience as a corporate manager. We nominate him as a candidate for Corporate Auditor in order for him to provide precise advice on the Company's management and since there is no problem with his independence in relationship with the Company. We believe he is suitable for serving as an Outside Corporate Auditor of the Company.
(Notes) | |
1. | Mr. Ryusuke Itakura is a candidate for Outside Corporate Auditor. |
2. | Mr. Ryusuke Itakura, a candidate for Outside Corporate Auditor, satisfies the requirements of independent officers |
stipulated by Tokyo Stock Exchange, Inc., Nagoya Stock Exchange, Inc. and Fukuoka Stock Exchange, respectively. | |
The Company has notified the stock exchanges that if this proposal to appoint Mr. Ryusuke Itakura as a Corporate | |
Auditor is approved, he will be an independent officer. | |
3. | If this proposal is approved, the Company plans to enter into an agreement with Mr. Ryusuke Itakura in accordance with |
Article 427, Paragraph 1 of the Companies Act, to limit the liability for damages set forth in Article 423, Paragraph 1 of | |
the same act to the amount stipulated by laws and regulations. | |
4. | The Company has concluded a directors and officers liability insurance contract with an insurance company, and all |
candidates for this election proposal will be insured under the contract. The insurance contract covers damages that may | |
arise from the insured directors and officers assuming liability for the execution of their duties or receiving claims related | |
to the pursuit of such liability. |
- 9 -
(Reference)
(1) Skill matrix of Directors and Corporate Auditors (planned) after this Annual General Meeting of Shareholders
The Company elects multiple Outside Directors within the limits of the number specified in the Companies Act and the Company's Articles of Incorporation, so that its Board of Directors is both diverse and effective, with a good balance of members who possess the knowledge, experience, and skills needed to effectively perform their roles and responsibilities. If Proposal 2 and Proposal 3 are approved as originally proposed, the composition of the Company's Directors and Corporate Auditors, and experience and expertise of each Director and Corporate Auditor are as follows:
IT / Digital | HR | Legal affairs / | |||||||
Name | Corporate | Sales / | Global / | Production / | transformation management / Sustainability Compliance / | Finance / | |||
management | Marketing | Business | R&D | (DX) | development | / ESG | Risk | Accounting | |
management | |||||||||
Directors
Corporate Auditors
Kazuhide Nakatomi
Kosuke Sugiyama
Kyu Saito
Nobuo Tsutsumi
Shinichi Murayama
Koji Takiyama
Yuichiro Anzai
Tetsugo Matsuo
Tamako Watanabe
Nobuyuki Nakatomi
Munehiko Hirano
Kentaro Watanabe
Ryusuke Itakura
● | ● | ● | ● | ||||
● | ● | ● | ● | ||||
● | ● | ● | |||||
● | ● | ● | |||||
● | ● | ● | |||||
● | ● | ● | ● | ||||
● | ● | ● | ● | ||||
● | ● | ||||||
● | ● | ● | |||||
● | |||||||
● | |||||||
● | ● | ||||||
● | ● | ● |
- 10 -
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Hisamitsu Pharmaceutical Co. Ltd. published this content on 25 April 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 April 2024 08:03:05 UTC.